ciliary body and choroid melanoma, medium/large size
Showing 1 - 25 of >10,000
Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Iris Melanoma Trial in
Completed
- Ciliary Body and Choroid Melanoma, Medium/Large Size
- +5 more
- Cixutumumab
- Laboratory biomarker analysis
-
Philadelphia, Pennsylvania
- +1 more
Feb 5, 2020
Uveal Melanoma, Uveal Melanoma, Posterior, Medium/Large Size, Eye Cancer, Intraocular Melanoma Trial in Stockholm (Melatonin)
Not yet recruiting
- Uveal Melanoma
- +2 more
-
Stockholm, SwedenSt. Erik Eye Hospital
Aug 14, 2022
Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Iris Melanoma Trial in
Completed
- Ciliary Body and Choroid Melanoma, Medium/Large Size
- +3 more
- recombinant interferon alfa-2b
- +2 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Feb 11, 2019
Iris Melanoma, Medium/Large Size Posterior Uveal Melanoma, Stage IIA Uveal Melanoma Trial in Los Angeles (External Beam
Terminated
- Iris Melanoma
- +6 more
- External Beam Radiation Therapy
- Laboratory Biomarker Analysis
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Jul 22, 2020
Acral Lentiginous Malignant Melanoma, Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma,
Completed
- Acral Lentiginous Malignant Melanoma
- +10 more
- cediranib maleate
-
Toronto, Ontario, CanadaPrincess Margaret Hospital Phase 2 Consortium
Jul 27, 2018
Intraocular Melanoma, Melanoma (Skin), Metastatic Cancer Trial in United States (melphalan, regional chemo, systemic chemo)
Completed
- Intraocular Melanoma
- +2 more
- melphalan
- +3 more
-
Santa Monica, California
- +11 more
Jun 15, 2021
Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)
Active, not recruiting
- Brain and Central Nervous System Tumors
- +9 more
- DNA analysis
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 28, 2021
Melanoma Trial in Nice (Protontherapy)
Terminated
- Melanoma
- Protontherapy
-
Nice, FranceCentre Antoine Lacassagne
Dec 12, 2022
Uveal Melanoma Trial in Ribeirão Preto (Melphalan Injection, Plaque brachytherapy)
Enrolling by invitation
- Uveal Melanoma
- Melphalan Injection
- Plaque brachytherapy
-
Ribeirão Preto, SP, BrazilHospital das Clinicas da Faculdade de Medicina de Ribeirao Preto
May 29, 2023
Uveal Melanoma Trial in Pittsburgh (Tebentafusp)
Not yet recruiting
- Uveal Melanoma
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Oct 5, 2023
Accomodation, Refractive Errors, Myopia Trial (1% atropine)
Recruiting
- Accomodation
- +3 more
- 1% atropine
-
Shanghai, Shanghai, ChinaShanghai Eye Diseases Prevention & Treatment Center
Jan 1, 2023
Renal Stone, Percutaneous Nephrolithotomy, Retrograde Intrarenal Surgery Trial in Cairo (mini-PNL, RIRS, SWL)
Recruiting
- Renal Stone
- +3 more
- mini-PNL
- +2 more
-
Cairo, EgyptUrology Department, Al-Azhar University Hospital
Nov 12, 2022
Choroidal Melanoma Trial in Aurora (1000CsK Silicon Oil Tamponade)
Completed
- Choroidal Melanoma
- 1000CsK Silicon Oil Tamponade
-
Aurora, ColoradoUniversity of Colorado Eye Center
Mar 4, 2022
Metastatic Melanoma Trial in Los Angeles (sunitinib malate, temozolomide)
Completed
- Metastatic Melanoma
- sunitinib malate
- temozolomide
-
Los Angeles, CaliforniaUniversity of California Los Angeles (UCLA)
Jul 30, 2020
Vascular Response to Brachytherapy Using Functional OCT
Active, not recruiting
- Uveal Melanoma
-
Portland, OregonOHSU Knight Cancer Institute
Jan 7, 2022
Atypical Choroid Plexus Papilloma, Choroid Plexus Carcinoma Trial in New York (Melphalan, Carboplatin, Topotecan)
Recruiting
- Atypical Choroid Plexus Papilloma
- Choroid Plexus Carcinoma
- Melphalan
- +2 more
-
New York, New YorkWeill Cornell Medicine
Aug 16, 2022
Optical Coherence Tomography (OCT) in Uveitis
Recruiting
- Uveitis
-
Portland, OregonOregon Health & Science University
Jul 13, 2021
Glaucoma, Myopia Trial (0.5% pilocarpine eye drops)
Not yet recruiting
- Glaucoma
- Myopia
- 0.5% pilocarpine eye drops
- (no location specified)
Apr 24, 2022
Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma
Recruiting
- Clinical Stage I Cutaneous Melanoma AJCC v8
- +8 more
- Ipilimumab
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 28, 2022
Corneal Biomechanics and Anterior Segment
Completed
- Ciliary Muscle Thickness
- +3 more
- Pentacam, Corvis ST and Casia2
-
Tianjin, Tianjin, ChinaTiajin Eye Hospital
Oct 28, 2023
Uveitis, Cataract, Inflammation Trial in Mölndal (Hydrophobic IOL: Vivinex (HOYA), Hydrophilic IOL: INCISE (Bausch+Lomb))
Active, not recruiting
- Uveitis
- +3 more
- Hydrophobic IOL: Vivinex (HOYA)
- Hydrophilic IOL: INCISE (Bausch+Lomb)
-
Mölndal, SwedenVastra Gotaland Region, Sahlgrenska University Hospital, Departm
Apr 26, 2022
Basal Cell Carcinoma, Basal Cell Carcinoma of Skin, Site Unspecified, Skin Cancer Trial in North Sydney (drug, procedure, other)
Recruiting
- Basal Cell Carcinoma
- +3 more
- Sonidegib
- +3 more
-
North Sydney, New South Wales, AustraliaMelanoma Institute Australia
Jun 9, 2022
Myopia, Progressive Trial in Waterloo (Novel spectacle lens design)
Active, not recruiting
- Myopia, Progressive
- Novel spectacle lens design
-
Waterloo, Ontario, CanadaCentre for Ocular Research and Education
Nov 3, 2022
Phase of Uveal Melanoma: A Prospective Multi-method Study
Not yet recruiting
- Uveal Melanoma
- Questionnaires and interviews
- (no location specified)
Oct 4, 2023
Blood Pressure on Retinal Capillary Rarefaction in Arterial
Recruiting
- Arterial Hypertension
- Blood Pressure, High
-
Vienna, AustriaMedical University of Vienna
Oct 19, 2023